British Hypertension Society guidelines for hypertension management 1999: Summary

British Medical Journal

Volumn 319, Issue 7210, 1999, Pages 630-635

  Ramsay, Lawrence E ^a   Williams, Bryan ^a   Johnston, G Dennis ^a   MacGregor, Graham A ^a   Poston, Lucilla ^a   Potter, John F ^a   Poulter, Neil R ^a   Russell, Gavin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM CHLORIDE; STATIN; THIAZIDE DIURETIC AGENT;

ALCOHOL CONSUMPTION; BLEEDING; BLOOD PRESSURE MEASUREMENT; BORDERLINE HYPERTENSION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; EXERCISE; FAT INTAKE; FITNESS; FOOD INTAKE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MEDICAL AUDIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; WEIGHT REDUCTION;

EID: 0033523419     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7210.630     Document Type: Review

References (29)

1. 1 Ramsay LE, Williams B, Johnston DG, MacGregor GA, Poston L, Potter JF, et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society, 1999. J Hum Hypertens 1999;13:569-92.
2. 2 Swales JD, Ramsay LE, Coope JR, Pocock SJ, Robertson JIS, Sever PS, et al. Treating mild hypertension. BMJ 1989;298:694-8.
3. 3 Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993;306:983-7.
4. 4 Hansson E, Zanchetti A, Carruthers SG, Dahlöf B, Eltnfeldt D, Julius S, et al for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998;351:1755-62.
5. 5 Curb JD, Pressel SL, Cutler JA, Savage PJ, Aplegate WB, Black H, et al for the Systolic Hypertension in the Elderly Program Co-operative Research Group. Advantage of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-92.
6. 6 United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
7. 7 Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Syst Eur Investigators. N Engl J Med 1999;340:677-84.
8. 8 Staessen JA, Fagard R, Thijs L. Cetis H, Arabidze CG, Birkenhager WH, et al for the Systolic Hypertension-Europe (Syst-Eur) Trial Investigators. Morbidity and mortality in the placebo-controlled European trial on isolated systolic hypertension in the elderly. Lancet 1997;360:757-64.
9. 9 Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al for the Treatment of Mild Hypertension Study Research Group. Treatment of mild hypertension study. Final results. JAMA 1993;270:713-24.
10. 10 Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.
11. 11 Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S on behalf of the HANE Trial Research Group. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ 1997;315:154-9.
12. 12 Appel LJ. Moore TJ, Obarzanek E, Vollmet WM, Svetkey LP, Sacks FM, et al for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.
13. 13 Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the trials of hypertension prevention, phase II. Arch Intern Med 1997;157:657-67.
14. 14 Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Kostis JB, et al for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998;279:839-46.
15. 15 Colhoun HM, Doug W, Poulter NR. Blood pressure screening, management and control in England, results from the health survey for England 1994. J Hypertens 1998;16:747-53.
16. 16 Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ 1998;317:167-71.
17. 17 O'Brien ET, Petrie JC, Littler WA, De Swiet M, Padfield PD, Dillon MJ, et al. Blood pressure measurement: recommendations of the British Hypertension Society. 3rd ed. London: BMJ Publishing Group, 1997.
18. 18 Alderman MH. Blood pressure management: individualized tretment based on absolute risk and the potential for benefit. Ann Intern Med 1993;119:329-35.
19. 19 Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80(suppl 2):S1-29.
20. 20 Standing Medical Advisory Committee. The use of statins. London: Department of Health, 1997.
21. 21 Scottish Intercollegiate Guideline Network. Lipids and the primary prevention of coronary heart disease. Edinburgh: SIGN, 1999. (pc47.cee.h2.ac.nk/ sign/; accessed 24 August 1999.)
22. 22 Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-45.
23. 23 Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998;16:1823-9.
24. 24 Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP). Lancet 1999; 353:611-5.
25. 25 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:3255-64.
26. 26 Thijs L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992;10:1103-9.
27. 27 Messerli FH, Grossman E, Goldbourt U. Are ß-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998;279:1903-7.
28. 28 Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998;351:233-41.
29. 29 Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.